Sutton Elizabeth F, Redman Leanne M
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.
Diabetes Metab Syndr Obes. 2016 Jul 18;9:213-6. doi: 10.2147/DMSO.S89839. eCollection 2016.
The development and dissemination of smart devices has cultivated a global environment of hyperconnectivity and increased our access to information. The paralleled launch and success of the Mobile Health industry has created a market of commercially available applications or "apps" along with tools or sensors, which allow the user to receive and collect personal health information. Apps and accompanying tools now allow an individual to "self-digitize" and, pertaining to weight management, monitor their body weight, caloric intake, physical activity, and more. These products possess the ability to improve the scalability of traditional in-person weight management services considering their near ubiquity, affordability, and capability to deliver information directly and personally to the user. However, similar to the dietary supplement market, the anecdotal value of these products has driven their popularity and acceptance by the general public without requirement of scientific validation or, in the area of weight management or diet/exercise, validation of the safety and efficacy by the Food and Drug Administration prior to market launch. By conducting a literature and clinical trial search, we found remarkably few active, completed, or published studies testing the efficacy of smart device applications using randomized controlled trials. Research efforts must be focused on illuminating the efficacy of behavioral interventions and remote self-monitoring for weight loss/maintenance treatment with true, randomized controlled trials.
智能设备的发展与普及营造了一个全球高度互联的环境,增加了我们获取信息的机会。移动健康产业的同步推出及其成功,催生了一个包含商业可用应用程序或“应用”以及工具或传感器的市场,这些应用和工具使用户能够接收和收集个人健康信息。如今,应用程序和配套工具让个人能够“自我数字化”,在体重管理方面,可以监测自己的体重、热量摄入、身体活动等。考虑到这些产品几乎无处不在、价格亲民且能够直接向用户个人传递信息,它们有能力提高传统面对面体重管理服务的可扩展性。然而,与膳食补充剂市场类似,这些产品的传闻价值推动了它们的普及并为公众所接受,却无需科学验证,在体重管理或饮食/运动领域,也无需在上市前经过美国食品药品监督管理局对安全性和有效性的验证。通过进行文献检索和临床试验搜索,我们发现使用随机对照试验来测试智能设备应用功效的活跃、完成或发表的研究少之又少。研究工作必须聚焦于通过真正的随机对照试验来阐明行为干预和远程自我监测对减肥/维持体重治疗的功效。